Activated epidermal growth factor receptor in ovarian cancer.
Hudson
Laurie G
LG
Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131-0001, USA. lhudson@salud.unm.edu
Zeineldin
Reema
R
Silberberg
Melina
M
Stack
M Sharon
MS
D002277:Carcinoma / Q000378:metabolism*; D045744:Cell Line, Tumor / Q000187:drug effects / Q000378:metabolism; D002470:Cell Survival; D002471:Cell Transformation, Neoplastic; D019008:Drug Resistance, Neoplasm; D004789:Enzyme Activation; D004815:Epidermal Growth Factor / Q000494:pharmacology / Q000502:physiology; D066246:ErbB Receptors / Q000502:physiology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018773:Genes, erbB-1; D006801:Humans; D008024:Ligands; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000502:physiology*; D010051:Ovarian Neoplasms / Q000378:metabolism*; D011379:Prognosis
D008024:Ligands; D009363:Neoplasm Proteins; D004815:Epidermal Growth Factor; D066246:ErbB Receptors